TRANSLATE

The lym Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the lym Hub cannot guarantee the accuracy of translated content. The lym and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

The Lymphoma & CLL Hub is an independent medical education platform, sponsored by Beigene, Johnson & Johnson and Roche, and supported through educational grants from Bristol Myers Squibb, Incyte, Lilly, and Pfizer. View funders.

Now you can support HCPs in making informed decisions for their patients

Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.

Find out more

Prof. Sonali Smith | ASH 2017 | Highlights of ASH 2017 in aggressive NHL

By Sonali Smith

Share:

Featured:

Sonali SmithSonali Smith

Dec 10, 2017


59th ASH Annual Meeting and Exposition, 9 - 12 Dec 2017, Atlanta, GA
Professor Sonali Smith
University of Chicago Medicine, Chicago, US

Interview topic: Highlights of ASH 2017 in aggressive NHL

Prof. Sonali Smith | ASH 2017 | Highlights of ASH 2017 in aggressive NHL